Celltrion Pharm Inc

Celltrion maintains a strong liquidity position with a current ratio of 1.66, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints in the medium term. The liquidity_fpt metric shows a healthy cash and equivalents balance of 49.87 billion KRW, but this is offset by long-term debt of 161.31 billion KRW, resulting in a net cash outflow. Profitability metrics show Celltrion is performing above the median for the pharmaceutical industry. The company's return on equity (ROE) of 8.89% and return on assets (ROA) of 5.1% are both strong, indicating efficient use of equity and assets to generate profit. Gross profit of 163.78 billion KRW and operating income of 55.88 billion KRW further support its profitability. Geographically, Celltrion's revenue is concentrated in South Korea, with limited exposure to international markets. The company's revenue concentration in a single market increases its vulnerability to domestic economic and regulatory shifts. No specific segment breakdown is available, but the lack of geographic diversification is a notable risk. Looking ahead, Celltrion's revenue is expected to grow, supported by its strong product portfolio and ongoing R&D efforts. The company's free cash flow of 43.16 billion KRW and operating cash flow of 86.43 billion KRW provide a solid foundation for future investments and expansion. However, capital expenditures of -17.92 billion KRW suggest a reduction in investment activity, which may impact long-term growth. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The risk assessment highlights the need for continued monitoring of debt levels and cash flow generation to maintain financial stability. Recent events include the publication of the latest financial results, which show a strong performance in terms of revenue and profitability. The company's ESG scores indicate moderate social responsibility and governance practices, with a high ESG controversies score suggesting potential reputational risks.